Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.8399
-0.0855 (-9.24%)
At close: Nov 20, 2026, 4:00 PM EST
0.8700
+0.0301 (3.58%)
After-hours: Nov 20, 2026, 7:51 PM EST
Palisade Bio Stock Forecast
PALI's stock price has decreased by -61.29% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 10 analysts polled by S&P Global, Palisade Bio stock has a consensus rating of "Strong Buy" and an average price target of $8.70. The average 1-year stock price forecast is 935.84% higher than the current stock price, while the lowest is $5.00 (+495.31%) and the highest is $16 (+1,804.99%).
Price Target: $8.70 (+935.84%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Palisade Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Reiterates $7 | Buy | Reiterates | $7 | +733.43% | Nov 13, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $8 | Buy | Reiterates | $8 | +852.49% | Nov 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $25 → $16 | Buy | Maintains | $25 → $16 | +1,804.99% | Nov 11, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $8 | Buy | Maintains | $8 | +852.49% | Nov 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 → $5 | Buy | Reiterates | $7 → $5 | +495.31% | Nov 11, 2026 |
Financial Forecast
Revenue This Year
500.00K
Revenue Next Year
n/a
from 500.00K
Decreased by -100.00%
EPS This Year
-0.24
from -0.30
EPS Next Year
-0.29
from -0.24
EPS and Forward PE are based on non-GAAP adjusted numbers.